The coronavirus pandemic caused global devastation and put unprecedented
pressure on health care facilities world-wide. The response to the
pandemic differed across the world as countries faced different
challenges. Due to the novelty of this virus and its global effects,
published guidance is currently limited to best practice and small-scale
trials, however, globally, large-scale clinical trials are now underway.
This review summarises the international response to coronavirus with
respect to gynaecological oncology and suggests potential interventions
to limit its spread during a resurgence or in the event of a future
global pandemic.